BJ
Beijing Tong Ren Tang Chinese Medicine Company Limited
BJTRF · OTC
$0.65 +0.00% (+$0.00)
Market Cap $4.26B
P/E Ratio 10.72x
Div. Yield 15.74%
ROE 9.65%
Bulios Fair Price
$0.75
15.7% upside
Current Price
$0.65
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BJTRF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
96 /100
Cheap P/FCF 5.15x
P/S 2.81x
P/B 1.02x
Growth
26 /100
Declining Rev. growth 4.35%
FCF growth 16.84%
Book val. growth 5.16%
Profitability
100 /100
Strong Net margin 26.25%
Op. margin 31.29%
FCF margin 54.65%
Quality
48 /100
Average ROE 9.65%
ROA 8.52%
Asset turnover 0.32x
Debt
100 /100
Low Current ratio 19.65x
Int. coverage 83.67x
Net debt/EBITDA -3.67x
Stability
24 /100
Unstable Rev. volatility 446.62%
EPS volatility 388.42%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BJTRF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Wang Chi
Employees
780
Headquarters
Hong Kong
Upcoming events
01 APR
Earnings
Upcoming earnings report